Substrate receptors of proteasomes
© 2018 Cambridge Philosophical Society..
Proteasomes are responsible for the turnover of most cellular proteins, and thus are critical to almost all cellular activities. A substrate entering the proteasome must first bind to a substrate receptor. Substrate receptors can be classified as ubiquitin receptors and non-ubiquitin receptors. The intrinsic ubiquitin receptors, including proteasome regulatory particle base subunits 1, 10 and 13 (Rpn1, Rpn10, and Rpn13), determine the capability of the proteasome to recognize a ubiquitin chain, and thus provide selectivity for the 26S proteasome. However, the non-ubiquitin receptors, including proteasome activator 200 (PA200) and PA28γ, have received great attention due to their remarkable compensatory roles relative to canonical ubiquitin-mediated proteasomal degradation. Herein we review recent advances in understanding the contributions of these substrate receptors to proteasomal degradation, and introduce their substrates and interacting factors. We also provide insights into their biological functions related to spermatogenesis, immune responses, cellular homeostasis, and tumour development. Finally, we summarize advances in developing small-molecule inhibitors of these substrate receptors and discuss their potential as drug targets.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Zur Gesamtaufnahme - volume:93 |
---|---|
Enthalten in: |
Biological reviews of the Cambridge Philosophical Society - 93(2018), 4 vom: 16. Nov., Seite 1765-1777 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Jiang, Tian-Xia [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 25.03.2019 Date Revised 25.03.2019 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/brv.12419 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM283797339 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM283797339 | ||
003 | DE-627 | ||
005 | 20231225041728.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/brv.12419 |2 doi | |
028 | 5 | 2 | |a pubmed24n0945.xml |
035 | |a (DE-627)NLM283797339 | ||
035 | |a (NLM)29732666 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Jiang, Tian-Xia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Substrate receptors of proteasomes |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.03.2019 | ||
500 | |a Date Revised 25.03.2019 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2018 Cambridge Philosophical Society. | ||
520 | |a Proteasomes are responsible for the turnover of most cellular proteins, and thus are critical to almost all cellular activities. A substrate entering the proteasome must first bind to a substrate receptor. Substrate receptors can be classified as ubiquitin receptors and non-ubiquitin receptors. The intrinsic ubiquitin receptors, including proteasome regulatory particle base subunits 1, 10 and 13 (Rpn1, Rpn10, and Rpn13), determine the capability of the proteasome to recognize a ubiquitin chain, and thus provide selectivity for the 26S proteasome. However, the non-ubiquitin receptors, including proteasome activator 200 (PA200) and PA28γ, have received great attention due to their remarkable compensatory roles relative to canonical ubiquitin-mediated proteasomal degradation. Herein we review recent advances in understanding the contributions of these substrate receptors to proteasomal degradation, and introduce their substrates and interacting factors. We also provide insights into their biological functions related to spermatogenesis, immune responses, cellular homeostasis, and tumour development. Finally, we summarize advances in developing small-molecule inhibitors of these substrate receptors and discuss their potential as drug targets | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Review | |
650 | 4 | |a PA200 | |
650 | 4 | |a PA28γ | |
650 | 4 | |a Rpn1 | |
650 | 4 | |a Rpn10 | |
650 | 4 | |a Rpn13 | |
650 | 4 | |a drug targets | |
650 | 4 | |a proteasomal degradation | |
650 | 4 | |a substrate receptor | |
650 | 7 | |a Ubiquitinated Proteins |2 NLM | |
650 | 7 | |a Ubiquitins |2 NLM | |
650 | 7 | |a Proteasome Endopeptidase Complex |2 NLM | |
650 | 7 | |a EC 3.4.25.1 |2 NLM | |
700 | 1 | |a Zhao, Mei |e verfasserin |4 aut | |
700 | 1 | |a Qiu, Xiao-Bo |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Biological reviews of the Cambridge Philosophical Society |d 1945 |g 93(2018), 4 vom: 16. Nov., Seite 1765-1777 |w (DE-627)NLM000038326 |x 1469-185X |7 nnns |
773 | 1 | 8 | |g volume:93 |g year:2018 |g number:4 |g day:16 |g month:11 |g pages:1765-1777 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/brv.12419 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 93 |j 2018 |e 4 |b 16 |c 11 |h 1765-1777 |